Editorial
Published on 14 Apr 2022
Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.907131
- 1,912 views
- 4 citations
Type at least 3 characters
570 articles
Articles
Original Research
Published on 06 Apr 2022
Impact of the CYP2D6 Genotype on Metoprolol Tolerance and Adverse Events in Elderly Chinese Patients With Cardiovascular Diseases
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.876392
- 4,048 views
- 5 citations
Editorial
Published on 05 Apr 2022
Editorial: Emerging Technologies Powering Rare and Neglected Disease Diagnosis and Theraphy Development
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.877401
- 1,585 views
- 4 citations
Review
Published on 04 Apr 2022
Ethnic Diversity and Warfarin Pharmacogenomics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.866058
- 10,087 views
- 19 citations
Review
Published on 04 Apr 2022
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.831099
- 4,287 views
- 13 citations
Original Research
Published on 21 Mar 2022
The Identification of Novel CYP2D6 Variants in US Hmong: Results From Genome Sequencing and Clinical Genotyping
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.867331
- 3,484 views
- 7 citations
Clinical Trial
Published on 11 Mar 2022
The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.755469
- 3,209 views
- 8 citations
Perspective
Published on 03 Mar 2022
Beyond Circulating Tumor Cell Enumeration: Cell-Based Liquid Biopsy to Assess Protein Biomarkers and Cancer Genomics Using the RareCyte® Platform
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.835727
- 9,592 views
- 10 citations
Original Research
Published on 23 Feb 2022
Genetic Epidemiology of Medication Safety and Efficacy Related Variants in the Central Han Chinese Population With Whole Genome Sequencing
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.790832
- 3,195 views
- 4 citations
Brief Research Report
Published on 22 Feb 2022
560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.820082
- 1,841 views
- 3 citations
Original Research
Published on 22 Feb 2022
Use of a Baculovirus-Mammalian Cell Expression-System for Expression of Drug-Metabolizing Enzymes: Optimization of Infection With a Focus on Cytochrome P450 3A4
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.832931
- 6,705 views
- 4 citations
Review
Published on 18 Feb 2022
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.835136
- 16,408 views
- 19 citations
Review
Published on 10 Feb 2022
Pharmacogenetics in Primary Headache Disorders
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.820214
- 8,206 views
- 15 citations
Review
Published on 24 Jan 2022
Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.834129
- 6,977 views
- 12 citations
Systematic Review
Published on 21 Jan 2022
Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.779497
- 8,880 views
- 18 citations
Review
Published on 21 Jan 2022
Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.812830
- 4,799 views
- 4 citations